125 related articles for article (PubMed ID: 15340521)
1. [Development of hygromycin-resistant packaging cell line for hepatitis B virus-derived vectors].
Hu DR; Sun DX; Xiong JH; Wu GH; Hu XL; Li J; Fan GR; Han JQ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):28-30. PubMed ID: 15340521
[TBL] [Abstract][Full Text] [Related]
2. [Anti-HBV effects of genetically engineered replication-defective HBV with combined expression of antisense RNA and dominant negative mutants of core protein and construction of first-generation packaging cell line for HBV vector].
Sun DX; Hu DR; Wu GH; Hu XL; Li J; Fan GR
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):260-4. PubMed ID: 12223133
[TBL] [Abstract][Full Text] [Related]
3. [Study on anti-HBV effects of genetically engineered replication-defective hepatitis B virus expressing dominant negative mutants of core protein].
Sun DX; Liu FJ; Hu DR; Wu GH; Hu XL; Han JQ; Li J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Jun; 18(2):145-9. PubMed ID: 15340503
[TBL] [Abstract][Full Text] [Related]
4. [Stable cell line for secretion of replication-defective hepatitis B virus vector expressing blasticidin resistant gene].
Liu JX; Sun DX; Cao ZC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):316-8. PubMed ID: 20108785
[TBL] [Abstract][Full Text] [Related]
5. [Construction and expression of recombinant retrovirus vector carrying HBV vector].
Sun D; Hu D; Wu G; Hu X; Li J; Fan G
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):162-5. PubMed ID: 12196831
[TBL] [Abstract][Full Text] [Related]
6. [Stable expression of HBV C gene mutants in immortalized human B-cell lines].
Zhang MX; Zhou FY; Diao ZH; He HT; Hou JL; Luo KX
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):725-9. PubMed ID: 16793585
[TBL] [Abstract][Full Text] [Related]
7. [Comparisons of the characteristics and mechanisms of HBV replication in QSG-7701 and HepG2 cell lines].
Pan XB; Zhu L; Gao Y; Chen HS; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):83-7. PubMed ID: 17362629
[TBL] [Abstract][Full Text] [Related]
8. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
[TBL] [Abstract][Full Text] [Related]
9. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.
Villet S; Billioud G; Pichoud C; Lucifora J; Hantz O; Sureau C; Dény P; Zoulim F
Gastroenterology; 2009 Jan; 136(1):168-176.e2. PubMed ID: 18996386
[TBL] [Abstract][Full Text] [Related]
11. [Effects of partial deletion in the core promoter of hepatitis B virus genome on viral antigen expressions].
Peng J; Luo KX; Hou JL; Guo YB; Wang ZH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):306-8. PubMed ID: 12390729
[TBL] [Abstract][Full Text] [Related]
12. [Replication and encapsidation of HBV mutants with the truncated C gene].
Han JQ; Hu DR; Xiong JH; Hu XL; Fan GR; Li J; Liu CY; Di YP; Wu YP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):39-42. PubMed ID: 15340524
[TBL] [Abstract][Full Text] [Related]
13. [Approach to transforming hepatitis B virus as a gene therapeutic vector].
Han JQ; Hu DR; Hu XL; Sun DX; Fan GR; Liu CY; Wu YP
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):344-6. PubMed ID: 12837212
[TBL] [Abstract][Full Text] [Related]
14. [Adenovirus-mediated transduction of HBV/C genome into HepG2 cell line].
Zhou B; Liang MF; Li WD; Wang C; Wang ZH; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1764-7. PubMed ID: 18971166
[TBL] [Abstract][Full Text] [Related]
15. [Construction of recombinant replication competent plasmids containing HBV genome with mutations of precore and basic core promoter].
Wang Y; Jiang D; Wei L; Chen HS; Cong X; Fei R; Wang Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):218-22. PubMed ID: 15640852
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
17. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
18. [Expression of HBcAg in eukaryotic cells by retroviral vector mediated gene transfer].
Ding CL; Yao K; Zhang TT; Xu JY; Xu L; Peng GY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):81-4. PubMed ID: 12870027
[TBL] [Abstract][Full Text] [Related]
19. A hepatocellular carcinoma cell line producing mature hepatitis B viral particles.
Fellig Y; Almogy G; Galun E; Ketzinel-Gilad M
Biochem Biophys Res Commun; 2004 Aug; 321(2):269-74. PubMed ID: 15358171
[TBL] [Abstract][Full Text] [Related]
20. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
